Who is generally a candidate Adults 18 and older with a BMI of 30 or higher (obesity), or Adults with a BMI of 27 or higher plus at least one weight-related condition: type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea No disqualifying personal or family medical history (see below) Willing to attend an in-person evaluation and follow-up visits during titration Who we generally do not prescribe to Personal or family history of medullary thyroid carcinoma or MEN2 syndrome (multiple endocrine neoplasia type 2) History of pancreatitis Severe gastroparesis or other significant gastrointestinal motility disease Pregnancy , breastfeeding, or actively planning pregnancy An active eating disorder Known hypersensitivity to semaglutide, tirzepatide, or a formulation's inactive ingredients We also look at what else is driving your case before deciding a GLP-1 is the right tool
10.1016/j.brainres.2018.08.022 91 WangY.LimK.NormandinM.ZhaoX.ClineG
GLP-1 promotes islet neogenesis, lowers blood glucose levels, upregulates Pdx1 expression, and increases -cell mass in db/db mice (Stoffers et al., 2000)
"Ozzy's having a go at me because he says I look like Mrs
This interdependence highlights the benefits of using both
The B12 does not affect the tirzepatide concentration or your unit draw